Summary
CME Group Inc. reported strong performance for the fiscal year ended December 31, 2022, with total revenues reaching $5.02 billion, a 7% increase year-over-year. This growth was primarily driven by a 10% rise in clearing and transaction fees, which benefited from an 18% increase in total contract volume. Key drivers for the volume increase included higher volatility in interest rate and equity index markets, influenced by inflation and Federal Reserve monetary policy. The company also saw a 6% increase in market data and information services revenue. Despite higher licensing and fee agreements expenses, total operating expenses decreased by 2% due to lower compensation and benefits costs, and professional fees. This led to an improved operating margin of 60.1%. Net income attributable to CME Group rose by 2% to $2.69 billion, resulting in diluted earnings per share of $7.40. The company also demonstrated robust cash flow from operations, increasing by 27% to $3.06 billion, supporting strategic investments and shareholder returns.
Financial Highlights
44 data points| Revenue | $5.02B |
| Operating Expenses | $2.00B |
| Operating Income | $3.02B |
| Net Income | $2.69B |
| EPS (Basic) | $7.41 |
| EPS (Diluted) | $7.40 |
| Shares Outstanding (Basic) | 358.71M |
| Shares Outstanding (Diluted) | 359.18M |
Key Highlights
- 1Total revenues increased by 7% to $5.02 billion in 2022.
- 2Clearing and transaction fees grew by 10% to $4.14 billion, driven by an 18% increase in total contract volume.
- 3Interest rate and equity index products experienced significant volume growth due to market volatility.
- 4Operating expenses decreased by 2% year-over-year, leading to an improved operating margin of 60.1%.
- 5Net income attributable to CME Group increased by 2% to $2.69 billion, with diluted EPS of $7.40.
- 6Cash flow from operations increased by 27% to $3.06 billion.
- 7The company made a strategic investment of $410 million in S&P Dow Jones Indices LLC.